ALEXIS LOPEZ: Open Payments
NPI 1275242158 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,684 in 80 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $860 · 2025 $2,684
Food & beverage: $2,384Education: $300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $247 |
| E.R. Squibb & Sons, L.L.C. | 10 | $209 |
| Janssen Biotech, Inc. | 3 | $193 |
| Daiichi Sankyo Inc. | 8 | $188 |
| PFIZER INC. | 8 | $180 |
| Novartis Pharmaceuticals Corporation | 6 | $157 |
| BeOne Medicines USA, Inc. | 1 | $150 |
| Merck Sharp & Dohme LLC | 5 | $129 |
| Incyte Corporation | 2 | $129 |
| Amgen Inc. | 1 | $125 |
Products named: BRUKINSA, RYBREVANT, BLINCYTO, KEYTRUDA, Lenvima, SCEMBLIX, Enhertu, ELREXFIO.
Industry payments across CA — which companies pay providers there.
